Novel therapeutic approaches for shock and systemic inflammation
Sepsis is the leading cause of mortality in non-coronary intensive care units and its incidence is set to rise. Despite advances in patient care, novel therapeutic interventions (with the exception of activated protein C) have failed to demonstrate benefit in clinical trials. High density lipoprotei...
Main Author: | Murch, Oliver Dominic |
---|---|
Published: |
Queen Mary, University of London
2007
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.582636 |
Similar Items
-
Beneficial effects of statins on the microcirculation during sepsis
by: McGown, Caroline Christina
Published: (2009) -
The role of protein tyrosine phosphatases in regulation of lipopolysaccharide-induced NFκB activation in rat aortic smooth muscle cells
by: Forbes, Karen
Published: (2005) -
Significant and selective modulation of function and survival in vitro of human dendritic cells (DCs) and T cell subsets by N-(3-oxododecanoyl)-L-homoserine lactones : a paradigm for understanding dysfunction of host defences in vivo in sepsis in man
by: Boontham, Pisake
Published: (2005) -
Mitochondrial dysfunction in critical illness
by: Brealey, David Andrew
Published: (2004) -
Tissue protein catabolism in sepsis : mechanisms, and modulation by nutrition, glutamine and recombinant human growth hormone
by: O'Leary, Michael James
Published: (2004)